Central Trust Company’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,630
| Closed | -$536K | – | 1444 |
|
|
2023
Q3 | $536K | Sell |
4,630
-1,438
| -24% | -$166K | 0.02% | 395 |
|
|
2023
Q2 | $624K | Sell |
6,068
-2,123
| -26% | -$218K | 0.02% | 383 |
|
|
2023
Q1 | $894K | Sell |
8,191
-2,752
| -25% | -$300K | 0.03% | 323 |
|
|
2022
Q4 | $1.25M | Sell |
10,943
-14,337
| -57% | -$1.63M | 0.04% | 266 |
|
|
2022
Q3 | $1.56M | Sell |
25,280
-8,399
| -25% | -$520K | 0.05% | 229 |
|
|
2022
Q2 | $2.69M | Sell |
33,679
-6,286
| -16% | -$501K | 0.09% | 178 |
|
|
2022
Q1 | $4.2M | Buy |
39,965
+1,921
| +5% | +$202K | 0.12% | 146 |
|
|
2021
Q4 | $4.1M | Buy |
38,044
+1,274
| +3% | +$137K | 0.12% | 153 |
|
|
2021
Q3 | $4.03M | Buy |
36,770
+2,998
| +9% | +$328K | 0.14% | 130 |
|
|
2021
Q2 | $3.16M | Buy |
33,772
+7,530
| +29% | +$705K | 0.11% | 156 |
|
|
2021
Q1 | $2.42M | Buy |
26,242
+23,621
| +901% | +$2.17M | 0.09% | 185 |
|
|
2020
Q4 | $192K | Buy |
2,621
+10
| +0.4% | +$733 | 0.01% | 483 |
|
|
2020
Q3 | $203K | Sell |
2,611
-1,850
| -41% | -$144K | 0.01% | 448 |
|
|
2020
Q2 | $248K | Buy |
4,461
+4,205
| +1,643% | +$234K | 0.01% | 411 |
|
|
2020
Q1 | $8K | Buy |
256
+20
| +8% | +$625 | ﹤0.01% | 907 |
|
|
2019
Q4 | $9K | Sell |
236
-30
| -11% | -$1.14K | ﹤0.01% | 969 |
|
|
2019
Q3 | $7K | Buy |
266
+230
| +639% | +$6.05K | ﹤0.01% | 984 |
|
|
2019
Q2 | $0 | Sell |
36
-312
| -90% | – | ﹤0.01% | 1207 |
|
|
2019
Q1 | $9K | Sell |
348
-72
| -17% | -$1.86K | ﹤0.01% | 931 |
|
|
2018
Q4 | $8K | Sell |
420
-460
| -52% | -$8.76K | ﹤0.01% | 962 |
|
|
2018
Q3 | $17K | Buy |
+880
| New | +$17K | ﹤0.01% | 875 |
|
|
2017
Q3 | – | Sell |
-108
| Closed | -$1K | – | 1403 |
|
|
2017
Q2 | $1K | Buy |
+108
| New | +$1K | ﹤0.01% | 1218 |
|